Drug executives say only their GLP-1 drugs are safe for treating obesity and diabetes as they wage a year-long campaign to ...

The FDA’s effort to crack down on compounded versions of popular GLP-1 weight-loss drugs has sparked backlash from patients and compounding pharmacies over concerns about access and ...

Especially in women’s health, this former regulatory gray area could help patients who have waited too long for FDA-approved solutions.

The FDA issued warning letters to 30 telehealth companies over misleading claims about compounded versions of popular ...

By Nancy Glick “As goes California, so goes the nation” is a phrase reflecting California’s reputation as a bellwether in ...

By Mariam Sunny March 3 (Reuters) - Strive Pharmacy said on Tuesday it has no plans to resume sales of a compounded version of Novo Nordisk's oral semaglutide, pushing back on an earlier media report ...

Ozempic maker's lawsuit, FDA enforcement could curtail sales of less expensive, compounded, versions of popular weight loss ...